John A Batsis1,2,3, Todd A Mackenzie2,3,4, Rebecca T Emeny2,3, Francisco Lopez-Jimenez5, Stephen J Bartels2,3. 1. Section of General Internal Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire. 2. Geisel School of Medicine at Dartmouth, Hanover, New Hampshire. 3. The Dartmouth Institute for Health Policy & Clinical Practice, Lebanon, New Hampshire. 4. Department of Biomedical Data Science, Dartmouth College, Hanover, New Hampshire. 5. Division of Cardiovascular Disease, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Abstract
BACKGROUND: The Foundation for the NIH Sarcopenia Project validated cutpoints for appendicular lean mass. We ascertained the relationship between low lean mass (LLM), obesity, and mortality and identified predictors in this subgroup. METHODS: A total of 4,984 subjects aged 60 years and older were identified from the National Health and Nutrition Examination Survey 1999-2004 linked to the National Death Index. LLM was defined using reduced appendicular lean mass (men < 19.75 kg; females < 15.02 kg). Obesity was defined using dual-energy x-ray absorptiometry body fat (males ≥ 25%; females ≥ 35%). LLM with obesity was defined using criteria for both LLM and obesity. Proportional hazard models determined mortality risk for LLM and LLM with obesity, separately (referent = no LLM and no LLM with obesity, respectively). RESULTS: Mean age was 71.1 ± 0.19 years (56.5% female). Median follow-up was 102 months (interquartile range: 78, 124) with 1,901 deaths (35.0%). Prevalence of LLM with obesity was 33.5% in females and 12.6% in males. In those with LLM, overall mortality risk was 1.49 (1.27, 1.73) in males and 1.19 (1.02, 1.40) in females. Mortality risk in LLM with obesity was 1.31 (1.11, 1.55) and 0.99 (0.85, 1.16) in males and females, respectively. Age, diabetes, history of stroke, congestive heart failure, cancer, and kidney disease were predictive of death. CONCLUSIONS: Risk of death is higher in subjects with LLM than with LLM and obesity. Having advanced age, diabetes, stroke, heart failure, cancer, and renal disease predict a worse prognosis in both classifications.
BACKGROUND: The Foundation for the NIH Sarcopenia Project validated cutpoints for appendicular lean mass. We ascertained the relationship between low lean mass (LLM), obesity, and mortality and identified predictors in this subgroup. METHODS: A total of 4,984 subjects aged 60 years and older were identified from the National Health and Nutrition Examination Survey 1999-2004 linked to the National Death Index. LLM was defined using reduced appendicular lean mass (men < 19.75 kg; females < 15.02 kg). Obesity was defined using dual-energy x-ray absorptiometry body fat (males ≥ 25%; females ≥ 35%). LLM with obesity was defined using criteria for both LLM and obesity. Proportional hazard models determined mortality risk for LLM and LLM with obesity, separately (referent = no LLM and no LLM with obesity, respectively). RESULTS: Mean age was 71.1 ± 0.19 years (56.5% female). Median follow-up was 102 months (interquartile range: 78, 124) with 1,901 deaths (35.0%). Prevalence of LLM with obesity was 33.5% in females and 12.6% in males. In those with LLM, overall mortality risk was 1.49 (1.27, 1.73) in males and 1.19 (1.02, 1.40) in females. Mortality risk in LLM with obesity was 1.31 (1.11, 1.55) and 0.99 (0.85, 1.16) in males and females, respectively. Age, diabetes, history of stroke, congestive heart failure, cancer, and kidney disease were predictive of death. CONCLUSIONS: Risk of death is higher in subjects with LLM than with LLM and obesity. Having advanced age, diabetes, stroke, heart failure, cancer, and renal disease predict a worse prognosis in both classifications.
Authors: Vasant Hirani; Fiona Blyth; Vasi Naganathan; David G Le Couteur; Markus J Seibel; Louise M Waite; David J Handelsman; Robert G Cumming Journal: J Am Med Dir Assoc Date: 2015-03-26 Impact factor: 4.669
Authors: Jill K Onesti; G Paul Wright; Sarah E Kenning; Mark T Tierney; Alan T Davis; Michael G Doherty; Mathew H Chung Journal: Pancreatology Date: 2016-02-03 Impact factor: 3.996
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Robert R McLean; Michelle D Shardell; Dawn E Alley; Peggy M Cawthon; Maren S Fragala; Tamara B Harris; Anne M Kenny; Katherine W Peters; Luigi Ferrucci; Jack M Guralnik; Stephen B Kritchevsky; Douglas P Kiel; Maria T Vassileva; Qian-Li Xue; Subashan Perera; Stephanie A Studenski; Thuy-Tien L Dam Journal: J Gerontol A Biol Sci Med Sci Date: 2014-05 Impact factor: 6.053
Authors: Peggy M Cawthon; Terri Blackwell; Steven R Cummings; Eric S Orwoll; Kate A Duchowny; Deborah M Kado; Katie L Stone; Kristine E Ensrud; Jane A Cauley; William J Evans Journal: J Gerontol A Biol Sci Med Sci Date: 2021-01-01 Impact factor: 6.053
Authors: John A Batsis; Curtis L Petersen; Rebecca S Crow; Summer B Cook; Courtney J Stevens; Lillian M Seo; Emma Brooks; Todd A Mackenzie Journal: Clin Nutr Date: 2019-11-04 Impact factor: 7.324
Authors: Neha M Kramer; Halena M Gazelka; Virginia H Thompson; John A Batsis; Keith M Swetz Journal: J Pain Symptom Manage Date: 2017-11-16 Impact factor: 3.612
Authors: Peggy M Cawthon; Stephanie L Harrison; Tara Rogers-Soeder; Katey Webber; Satya Jonnalagadda; Suzette L Pereira; Nancy Lane; Jane A Cauley; James M Shikany; Samaneh Farsijani; Lisa Langsetmo Journal: Geriatrics (Basel) Date: 2021-05-18